Use sterile handling techniques in the laboratory Evitar la contaminacin durante la reconstitucin y las extracciones Almacenar adecuadamente antes y despus de la reconstitucin Why choose Peptide Health
Its also used in chronic illness recovery and longevity protocols
Semaglutide Wegovy / Ozempic Mechanism: GLP-1 receptor agonist (single target) Weight loss: ~15-17% body weight (STEP trials, 68 weeks) Dosing: Weekly injection, titrated from 0.25mg to 2.4mg Common side effects: Nausea, vomiting, diarrhea, constipation (typically transient) Availability: Longer track record, more widely available Cardiovascular data: SELECT trial demonstrated 20% reduction in major cardiovascular events Tirzepatide Zepbound / Mounjaro Mechanism: Dual GLP-1 + GIP receptor agonist (two targets) Weight loss: ~20-22% body weight (SURMOUNT trials, 72 weeks) Dosing: Weekly injection, titrated from 2.5mg to 15mg Common side effects: Similar GI profile to semaglutide
Concentration is expressed as milligrams per milliliter (mg/mL)
The study found an association rather than a guaranteed protective effect, and an individuals overall risk depends far more on liver disease, viral hepatitis, alcohol use, metabolic health and family medical history
doi:10.1056/NEJMoa1109400